Cargando…
Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer
The majority of breast cancers (90–95%) arise due to mediators distinct from inherited genetic mutations. One major mediator of breast cancer involves chronic inflammation. M1 macrophages are an integral component of chronic inflammation and the breast cancer tumor microenvironment (TME). Previous s...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966261/ https://www.ncbi.nlm.nih.gov/pubmed/29849939 http://dx.doi.org/10.18632/oncotarget.24917 |
_version_ | 1783325431658708992 |
---|---|
author | Bednarczyk, Robert B. Tuli, Neha Y. Hanly, Elyse K. Rahoma, Ghada Ben Maniyar, Rachana Mittelman, Abraham Geliebter, Jan Tiwari, Raj K. |
author_facet | Bednarczyk, Robert B. Tuli, Neha Y. Hanly, Elyse K. Rahoma, Ghada Ben Maniyar, Rachana Mittelman, Abraham Geliebter, Jan Tiwari, Raj K. |
author_sort | Bednarczyk, Robert B. |
collection | PubMed |
description | The majority of breast cancers (90–95%) arise due to mediators distinct from inherited genetic mutations. One major mediator of breast cancer involves chronic inflammation. M1 macrophages are an integral component of chronic inflammation and the breast cancer tumor microenvironment (TME). Previous studies have demonstrated that up to 50% of the breast tumor comprise of tumor-associated macrophages (TAMs) and increased TAM infiltration has been associated with poor patient prognosis. Furthermore, breast cancer associated deaths are predominantly attributed to invasive cancers and metastasis with epithelial-mesenchymal transition (EMT) being implicated. In this study, we investigated the effects of cellular crosstalk between TAMs and breast cancer using an in vitro model system. M1 polarized THP-1 macrophage conditioned media (CM) was generated and used to evaluate cellular and functional changes of breast cancer lines T47D and MCF-7. We observed that T47D and MCF-7 exhibited a partial EMT phenotype in the presence of activated THP-1 CM. Additionally, MCF-7 displayed a significant increase in migratory and invasive properties. We conclude that M1 secretory factors can promote a partial EMT of epithelial-like breast cancer cells. The targeting of M1 macrophages or their secretory components may inhibit EMT and limit the invasive potential of breast cancer. |
format | Online Article Text |
id | pubmed-5966261 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-59662612018-05-30 Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer Bednarczyk, Robert B. Tuli, Neha Y. Hanly, Elyse K. Rahoma, Ghada Ben Maniyar, Rachana Mittelman, Abraham Geliebter, Jan Tiwari, Raj K. Oncotarget Research Paper The majority of breast cancers (90–95%) arise due to mediators distinct from inherited genetic mutations. One major mediator of breast cancer involves chronic inflammation. M1 macrophages are an integral component of chronic inflammation and the breast cancer tumor microenvironment (TME). Previous studies have demonstrated that up to 50% of the breast tumor comprise of tumor-associated macrophages (TAMs) and increased TAM infiltration has been associated with poor patient prognosis. Furthermore, breast cancer associated deaths are predominantly attributed to invasive cancers and metastasis with epithelial-mesenchymal transition (EMT) being implicated. In this study, we investigated the effects of cellular crosstalk between TAMs and breast cancer using an in vitro model system. M1 polarized THP-1 macrophage conditioned media (CM) was generated and used to evaluate cellular and functional changes of breast cancer lines T47D and MCF-7. We observed that T47D and MCF-7 exhibited a partial EMT phenotype in the presence of activated THP-1 CM. Additionally, MCF-7 displayed a significant increase in migratory and invasive properties. We conclude that M1 secretory factors can promote a partial EMT of epithelial-like breast cancer cells. The targeting of M1 macrophages or their secretory components may inhibit EMT and limit the invasive potential of breast cancer. Impact Journals LLC 2018-03-23 /pmc/articles/PMC5966261/ /pubmed/29849939 http://dx.doi.org/10.18632/oncotarget.24917 Text en Copyright: © 2018 Bednarczyk et al. http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited. |
spellingShingle | Research Paper Bednarczyk, Robert B. Tuli, Neha Y. Hanly, Elyse K. Rahoma, Ghada Ben Maniyar, Rachana Mittelman, Abraham Geliebter, Jan Tiwari, Raj K. Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer |
title | Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer |
title_full | Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer |
title_fullStr | Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer |
title_full_unstemmed | Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer |
title_short | Macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer |
title_sort | macrophage inflammatory factors promote epithelial-mesenchymal transition in breast cancer |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5966261/ https://www.ncbi.nlm.nih.gov/pubmed/29849939 http://dx.doi.org/10.18632/oncotarget.24917 |
work_keys_str_mv | AT bednarczykrobertb macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer AT tulinehay macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer AT hanlyelysek macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer AT rahomaghadaben macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer AT maniyarrachana macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer AT mittelmanabraham macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer AT geliebterjan macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer AT tiwarirajk macrophageinflammatoryfactorspromoteepithelialmesenchymaltransitioninbreastcancer |